Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christian Drosten and Leif Sander.
Christian Drosten
Connection Strength
1.569
Leif Sander
  1. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
    View in: PubMed
    Score: 0.240
  2. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021 07 09; 373(6551).
    View in: PubMed
    Score: 0.237
  3. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
    View in: PubMed
    Score: 0.222
  4. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
    View in: PubMed
    Score: 0.061
  5. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021 08 11; 12(1):4869.
    View in: PubMed
    Score: 0.060
  6. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.059
  7. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
    View in: PubMed
    Score: 0.059
  8. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis. 2021 08; 27(8):2169-2173.
    View in: PubMed
    Score: 0.059
  9. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
    View in: PubMed
    Score: 0.059
  10. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021 Aug; 49(4):757-762.
    View in: PubMed
    Score: 0.059
  11. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol. 2021; 12:629185.
    View in: PubMed
    Score: 0.058
  12. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2020; 11:628971.
    View in: PubMed
    Score: 0.058
  13. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021 06; 39(6):705-716.
    View in: PubMed
    Score: 0.058
  14. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020 11 12; 183(4):1058-1069.e19.
    View in: PubMed
    Score: 0.057
  15. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
    View in: PubMed
    Score: 0.056
  16. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.056
  17. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020 08; 38(8):970-979.
    View in: PubMed
    Score: 0.056
  18. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst. 2020 07 22; 11(1):11-24.e4.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.